1. Home
  2. TENX vs BUUU Comparison

TENX vs BUUU Comparison

Compare TENX & BUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$11.87

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

BUUU

BUUU Group Limited Class A Ordinary Share

HOLD

Current Price

$19.00

Market Cap

264.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
BUUU
Founded
1967
2017
Country
United States
Hong Kong
Employees
N/A
16
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
264.6M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
TENX
BUUU
Price
$11.87
$19.00
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
545.5K
13.1K
Earning Date
05-15-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$347.19
Revenue Growth
N/A
N/A
52 Week Low
$5.34
$3.97
52 Week High
$18.38
$25.99

Technical Indicators

Market Signals
Indicator
TENX
BUUU
Relative Strength Index (RSI) 43.07 55.60
Support Level $10.87 $13.24
Resistance Level $12.75 $19.09
Average True Range (ATR) 0.67 3.37
MACD 0.06 -0.34
Stochastic Oscillator 51.11 34.88

Price Performance

Historical Comparison
TENX
BUUU

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About BUUU BUUU Group Limited Class A Ordinary Share

BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.

Share on Social Networks: